Pharma reps meet Star Wars stardom

A long time ago in an imaginary galaxy far, far away, Merck was training an elite squad of Vioxx reps--the V squad--to overcome obstacles to the painkiller's success. Could they beat the futuristic "obstaclizer" and meet their sales goals? See the videos to find out. Report

Suggested Articles

With a brand new approval for Adakveo under its belt, Novartis Sunday flaunted an analysis showing the drug could cut patient hospitalizations by 40%.

BeiGene only just won its first Brukinsa nod in MCL. But it’s already pushing to join the CLL field, and Sunday it rolled out more data.

How long can one infusion of CAR-T drug Yescarta continue helping patients with refractory large B-cell lymphoma? Pretty long, Gilead showed Saturday.